Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Andrew Karim, Kader"'
Autor:
Jonathan Hsu, Sung Gu Kang, Fady Ghali, Amirali Salmasi, Christina Jamieson, Sanghee Lee, Michelle Muldong, Andrew Karim Kader
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Upper urinary tract urothelial carcinoma (UTUC) affects both men and women and accounts for approximately 5% of urothelial malignancies and 5 to 10% of renal cancers. Alt...
Autor:
Yair Lotan, Siamak Daneshmand, Badrinath R. Konety, Sima P. Porten, Andrew Karim Kader, Neal D. Shore, Tony Lough
Publikováno v:
European Urology. 76:238-243
Background Cxbladder diagnostic tests combine genomic information from urinary mRNA with phenotypic information to either rule out low-risk individuals or identify patients at a high risk of urothelial carcinoma (UC). Objective To evaluate the perfor
Autor:
E David, Crawford, Gerald, Andriole, Stephen J, Freedland, Marc, Garnick, Leonard G, Gomella, Jonathan, Henderson, Celestia Tia, Higano, Andrew Karim, Kader, Christopher, Kane, Thomas E, Keane, Phillip J, Koo, Daniel P, Petrylak, Robert E, Reiter, Susan F, Slovin, Evan Y, Yu
Publikováno v:
The Canadian journal of urology. 27(5)
INTRODUCTION To interpret data and update the traditional categorization of prostate cancer in order to help treating clinicians make more informed decisions. These updates include guidance regarding how to best use next generation imaging (NGI) with
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Prostate cancer (PCa) risk calculators outperform provider intuition in predicting PCa at time of biopsy. We sought to investigate the impact of adding Prompt – Prostate ...
Publikováno v:
The Journal of Urology. 203:e1145-e1146
INTRODUCTION AND OBJECTIVE:Broad-based Prostate-Specific Antigen (PSA) prostate cancer (PCa) screening has saved lives but at substantial financial and human cost due to the number of low risk men ...
Autor:
Paul L. Nguyen, John P. Einck, Arno J. Mundt, Andrew Karim Kader, Brent S. Rose, Stephen Ryan, Alex K. Bryant, Reith R Sarkar, Anthony V. D'Amico, J. Kellog Parsons, Rana R. McKay, James D. Murphy, Christopher J. Kane, Benjamin J. Hulley
Publikováno v:
JAMA Intern Med
IMPORTANCE: 5α-Reductase inhibitors (5-ARIs), commonly used to treat benign prostatic hyperplasia, reduce serum prostate-specific antigen (PSA) concentrations by 50%. The association of 5-ARIs with detection of prostate cancer in a PSA-screened popu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a642cf36be98a6b418c0c6bf1127dc77
https://europepmc.org/articles/PMC6503564/
https://europepmc.org/articles/PMC6503564/
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:The management of the lower urinary tract continence can be complex in patients with neurogenic bladder. Oftentimes, many procedures maybe attempted in an effort to achi...
Autor:
Donna E. Hansel, Steven S. Raman, Joshua M. Kuperman, David S. Karow, Nathan S. White, Daniel Margolis, Ryan L. Brunsing, Nikdokht Farid, J. Kellogg Parsons, Rebecca Rakow-Penner, Anders M. Dale, Christopher J. Kane, Natalie M. Schenker-Ahmed, Tyler M. Seibert, Ahmed Shabaik, Andrew Karim Kader, Santosh Kesari, Hauke Bartsch, Carrie R. McDonald
Publikováno v:
Journal of Magnetic Resonance Imaging. 45:323-336
Author(s): Brunsing, Ryan L; Schenker-Ahmed, Natalie M; White, Nathan S; Parsons, J Kellogg; Kane, Christopher; Kuperman, Joshua; Bartsch, Hauke; Kader, Andrew Karim; Rakow-Penner, Rebecca; Seibert, Tyler M; Margolis, Daniel; Raman, Steven S; McDonal
Autor:
Andrew Karim Kader, Jason A. Efstathiou, James D. Murphy, Rana R. McKay, Alex K. Bryant, Brent S. Rose, John P. Einck, Christopher J. Kane, Arno J. Mundt, Loren K. Mell
Publikováno v:
International journal of radiation oncology, biology, physics, vol 101, iss 5
Bryant, AK; Kader, AK; McKay, RR; Einck, JP; Mell, LK; Mundt, AJ; et al.(2018). Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 101(5), 1188-1193. doi: 10.1016/j.ijrobp.2018.04.023. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/3v9686cs
Bryant, AK; Kader, AK; McKay, RR; Einck, JP; Mell, LK; Mundt, AJ; et al.(2018). Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 101(5), 1188-1193. doi: 10.1016/j.ijrobp.2018.04.023. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/3v9686cs
168 Background: The survival benefit of combined radiation therapy (RT) and androgen deprivation therapy (ADT) compared to ADT alone for clinically lymph node-positive prostate cancer remains controversial. Methods: We identified clinically node-posi
Autor:
Ahmed Shabaik, Zachary Hamilton, Mariah Z. Leivo, Leili Mirsadraei, Debashis Sahoo, Donna E. Hansel, Andrew Karim Kader, J.K. Parsons, Christopher J. Kane, Ithaar Derweesh
Publikováno v:
The American journal of surgical pathology. 42(1)
Urothelial carcinoma of the bladder invasive into lamina propria on biopsy or transurethral resection of bladder tumor, termed "T1" disease, progresses to muscularis propria invasion in a subset of patients. Prior studies have proposed histopathologi